August 27, 2020 - Page 16 of 19

TSX News - August 27, 2020

Aura Comments on the Secondary Public Offering of BDRs and the Request for Conversion of the BDR Program to Sponsored Level III

ROAD TOWN, British Virgin Islands, Aug. 27, 2020 (GLOBE NEWSWIRE) — Aura Minerals Inc. (TSX: ORA) (B3: AURA32) (the “Company” […]

NASDAQ Companies - August 27, 2020

MGP Ingredients Hires New Vice President of Information Technology

ATCHISON, Kan., Aug. 27, 2020 (GLOBE NEWSWIRE) — Jeffrey Ruger has joined MGP Ingredients, Inc., (Nasdaq: MGPI), a leading supplier […]

NASDAQ Companies - August 27, 2020

U.S. Court of Appeals Dismisses Securities Lawsuit Against ReWalk Robotics

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Aug. 27, 2020 (GLOBE NEWSWIRE) — ReWalk Robotics, Ltd. (Nasdaq: RWLK) (“ReWalk” […]

NASDAQ Companies - August 27, 2020

Agios to Present at the Citi 15th Annual BioPharma Virtual Conference on Wednesday, September 9, 2020

CAMBRIDGE, Mass., Aug. 27, 2020 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism […]

NASDAQ Companies - August 27, 2020

Aravive Strengthens Leadership Team with Appointment of Key Industry Veterans

HOUSTON, Aug. 27, 2020 (GLOBE NEWSWIRE) — Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company developing transformative therapeutics, today announced [...]

NASDAQ Companies - August 27, 2020

Kymera Therapeutics Appoints Dr. Richard Chesworth as Chief Scientific Officer

WATERTOWN, Mass., Aug. 27, 2020 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company focused on discovering and […]

NASDAQ Companies - August 27, 2020

Pluristem Launches FDA-Cleared COVID-19 Expanded Access Program, Enabling Patient Treatment Outside of Clinical Trial

HAIFA, Israel, Aug. 27, 2020 (GLOBE NEWSWIRE) — Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing a […]